Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02901483
What this trial is testing

PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
PharmaEngine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03726775
What this trial is testing

Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 61
Testing effectiveness (Phase 2)Study completedNCT00559156
What this trial is testing

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 46
Early research (Phase 1)Study completedNCT04196283
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 30
Testing effectiveness (Phase 2)Ended earlyNCT02068157
What this trial is testing

Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous CarcinomaRecurrent Lip and Oral Cavity Squamous Cell Carcinoma+4 more
Roswell Park Cancer Institute 3
Testing effectiveness (Phase 2)Looking for participantsNCT07030257
What this trial is testing

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more
Tasca Therapeutics 150
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Early research (Phase 1)Ended earlyNCT01987375
What this trial is testing

Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures

Who this might be right for
Head and Neck Cancer
Eben Rosenthal 1
Testing effectiveness (Phase 2)Study completedNCT02499120
What this trial is testing

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Pfizer 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT04609280
What this trial is testing

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

Who this might be right for
Head and Neck CancerOropharynx CancerOropharyngeal Squamous Cell Carcinoma
University of Maryland, Baltimore 52
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Post-approval studies (Phase 4)Not Yet RecruitingNCT07633613
What this trial is testing

Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)Metastatic Head and Neck Squamous Cell Carcinoma
Centre Antoine Lacassagne 110
Testing effectiveness (Phase 2)UnknownNCT05803915
What this trial is testing

Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy

Who this might be right for
Oral Squamous Cell Carcinoma
Peking Union Medical College Hospital 57
Early research (Phase 1)Study completedNCT01115790
What this trial is testing

Study in Participants With Advanced Cancer

Who this might be right for
Advanced CancerSquamous Cell CarcinomaCarcinoma, Squamous Cell of Head and Neck+3 more
Eli Lilly and Company 150
Testing effectiveness (Phase 2)Study completedNCT00003580
What this trial is testing

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
University of Tennessee
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Early research (Phase 1)Not Yet RecruitingNCT07741643
What this trial is testing

Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCC,Larynx, Pharynx and Oral CavitySquamous Cell CarcinomaHead and Neck Cancer+1 more
Vanderbilt-Ingram Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03944915
What this trial is testing

De-Escalation Therapy for Human Papillomavirus Negative Disease

Who this might be right for
Human Papilloma VirusSquamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+2 more
University of Chicago 35
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05343325
What this trial is testing

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University 25
Next Page